Work

Development of isourea-based covalent GPX4 inhibitors and structure–activity relationship analysis in ferroptosis induction

Year: 2026
Type: article
Abstract: N]-HSQC measurements support enhanced GPX4-ligand interaction under dodecylphosphocholine (DPC) membrane-mimetic conditions. Beyond defining the medicinal-chemistry characteristics of this isourea compound series, our work establishes non-retained leaving-group engineering as a strategy for developing covalent GPX4 inhibitors with tunable cellular and pharmacokinetic properties.
Language: English
Subfield: Cancer Research
Open Access status: gold
Estimated APC paid: $1,962
OpenAlex ID: W7225916458
FWCI:
Cites: 37
Cited by:
Related to: 10